Disclosures for "Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking"
-
Miss Veerappan has nothing to disclose.
-
The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.